Primary Navigation for the CDC Website
CDC en Espańol

2009-H1N1 Flu - Congressional Update

Centers for Disease Control and Prevention

2009 H1N1 Influenza Update Banner

We are providing this update to help inform Congress and congressional staff about the current status of 2009 H1N1 Influenza and related topics. This update will be issued on Fridays unless events dictate otherwise.  HHS’ Assistant Secretary for Legislation will also be hosting periodic telebriefings on 2009 H1N1. Questions should be directed to CDC/Washington at 202-245-0600.

Note: Green text indicates new information. Black text indicates background and other information also included in previous updates.

October 23, 2009 (Fall 2009; Issue 43)

In This Email (in Outlook and on some Blackberry devices, you can click on these headings and express to these sections):

Current 2009 H1N1 Situation Update

In the U.S. from August 30 – October 17, 2009, 8,204 laboratory confirmed influenza associated hospitalizations, 411 laboratory-confirmed influenza associated deaths, 21,823 pneumonia and influenza syndrome-based hospitalizations, and 2,416 pneumonia and influenza syndrome-based deaths, were reported to CDC.

A total of 95 deaths in children associated with 2009 H1N1 virus have been reported to CDC.

Currently, flu activity is increasing in most of the United States with 46 states reporting widespread influenza activity. See map below for updated view of influenza in the U.S.

Weekly Influenza activity

More information regarding 2009 H1N1 Influenza activity can be viewed here.

More information about CDC's 2009 H1N1 influenza surveillance system is available here.

Weekly updates on the global 2009 H1N1 Influenza situation can be found here.

Key Influenza Prevention Messages

All individuals should take these everyday steps to protect themselves from flu:

  • Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
  • Wash your hands often with soap and water. If soap and water are not available, use an alcohol-based hand rub.
  • Avoid touching your eyes, nose or mouth.
  • Try to avoid close contact with sick people.
  • If you are sick with flu-like illness, stay home for at least 24 hours after your fever is gone (without the use of a fever-reducing medicine) except to get medical care or for other necessities. Keep away from others to keep from making others sick.
  • Follow public health advice regarding school closures, avoiding crowds and other social distancing measures.
  • Be prepared in case you get sick and need to stay home. A supply of over-the-counter medicines, alcohol-based hand rubs, tissues and other related items might could be useful and help avoid the need to make trips out in public while you are sick and contagious.

General Seasonal Influenza Updates

  • Individuals should be encouraged to seek seasonal flu vaccine.
  • There are many millions of doses yet to be distributed this season. As distribution continues, however, some individuals may have to obtain the vaccine from a source other than their preferred provider.
  • As of October 16, 85 million doses, or 74 percent of the total seasonal influenza vaccine doses expected this season have been distributed in the private and public sectors.
  • It is estimated that the total number of doses that will be manufactured this year is approximately the same as the number of doses that were actually administered last season. Manufacturers now estimate that a total of 114 million doses will be brought to the U.S. market.
  • People can find seasonal vaccine by checking the American Lung Association web site that identifies clinics that have influenza vaccine available: http://www.flucliniclocator.org/
  • We are still early in flu season; there is still time for people to get vaccinated to protect themselves from becoming ill.
  • Many more individuals have been vaccinated against seasonal influenza this season than at the same time last year. This is most likely due to the early availability of vaccine.

2009 H1N1 Vaccination Information

Vaccine Production and Distribution

All states and the District of Columbia have placed orders for vaccine. As of October 21, 14,070,900 doses have been allocated and 11,282,200 doses have been shipped.

Since September 30, when the 2009 H1N1 vaccine was first made available to states to order, the number of doses that has been produced, distributed, and administered has grown steadily, and states are executing their plans for providing vaccine to high-priority populations.  While modest amounts of vaccine have been made available ahead of schedule, a series of manufacturing delays has caused significant reductions in the manufacturers’ projected vaccine output and the number of doses delivered so far.  Most reasons for these delays have now been overcome, and production of the vaccine components is proceeding as expected but on a revised schedule.  HHS is working closely with the vaccine manufacturers to get the vaccine supplies flowing to the public as vaccine becomes available.  Although we had hoped to have more vaccine distributed by this point, ultimately everyone who wants to receive the vaccine will be able to get vaccinated.  These current delays will not alter the per capita allotment basis for states, nor will it affect the method through which states are able to order and receive their allocated doses.   CDC is working closely with states to ensure that vaccine gets to the public as soon as we receive it, and CDC has worked with its distributors to ensure round-the-clock shipping capabilities and 24 hour turn-around time on distribution.  CDC continues to offer technical assistance to, and meets regularly with, states and other partners to improve the effectiveness of the vaccination program. Weekly updates on 2009 H1N1 vaccine allocated, ordered, and shipped are available here.

 See questions and answers about 2009 H1N1 Influenza vaccine distribution here.

To find out where 2009 H1N1 or seasonal flu vaccine is available near you, access the flu.gov vaccine locator here.

Vaccine Recommendations

  • Inactivated vaccines against both the seasonal and 2009 H1N1 influenza viruses can be received on the same day. Live 2009 H1N1 vaccine can be administered at the same visit as any other live or inactivated vaccine except seasonal live attenuated influenza vaccine. The seasonal vaccine is already available in many locations, however, and individuals are encouraged to get their seasonal flu vaccine as soon as possible.
  • For individuals needing more than one dose of the 2009 H1N1 vaccine, CDC recommends that the two doses be separated by approximately four weeks. If the second dose is separated from the first dose by at least 21 days, however, the second dose can be considered valid.
  • Vaccine will become increasingly available in a combination of settings such as vaccination clinics organized by local health departments, healthcare provider offices, schools, and other private settings, such as pharmacies and workplaces.
H1N1 FLU View map

Vaccine Safety

  • Neither the 2009 H1N1 influenza vaccine nor the 2009-2010 seasonal influenza vaccine have been associated with any unexpected adverse events.
  • The CDC and FDA closely monitor the safety of seasonal influenza and other vaccines licensed for use in the United States in cooperation with state and local health departments, healthcare providers, and other partners.
  • Clinical trials on 2009 H1N1 influenza vaccine began in July and are ongoing. Information from the trials indicates the vaccines are safe, and that one dose of vaccine provides protection to most healthy adults and children 10-17 years old. Children younger than 10 years should receive two doses of 2009 H1N1 flu vaccine. The trials are also seeking information on pregnant women and on immune-compromised individuals.
  • CDC and its partners are using several systems to monitor the safety of 2009 H1N1 monovalent influenza vaccine.  Two primary systems are the Vaccine Adverse Event Reporting System (VAERS), which is jointly operated with FDA, and the Vaccine Safety Datalink (VSD) Project.  

 Read more about the clinical trials here and 2009 H1N1 Influenza vaccine safety here.

Vaccine Financing and Reimbursement

  • Novel H1N1 vaccine is being procured and purchased by the federal government and made available for vaccinators at no cost.
  • Vaccination providers can not charge or bill for the 2009 H1N1 vaccine, though some may charge for administration of the vaccine.
  • Vaccine will be administered free of charge in public clinics and settings, and patients will not be charged for administration of 2009 H1N1 vaccine in such settings.  Most private health insurers are expected to reimburse providers for the cost of administration.

Protecting Healthcare Workers

On Wednesday, October 14, CDC released updated interim guidance on infection control measures to prevent transmission of the 2009 H1N1 influenza virus in healthcare facilities and protect healthcare workers against the virus.  The guidance recommends a comprehensive approach using a hierarchy of controls, including in order of importance: (1) eliminating potential exposures (e.g., taking steps to minimize outpatient visits by patients with mild influenza-like illness), (2) engineering controls (e.g., installing partitions in triage areas), (3) administrative controls (e.g., promoting and providing vaccination and enforcing exclusion of ill healthcare workers), and (4) personal protective equipment (e.g., respirators).  CDC's guidance continues to recommend the use of respiratory protection at least as protective as N95 respirators for healthcare personnel who are in close contact with patients with suspected or confirmed 2009 H1N1 influenza.  If a healthcare facility experiences a shortage of respirators, the guidance recommends that the facility prioritize the use of respirators for healthcare workers at the greatest risk of exposure and with risk factors for influenza-related complications and that other healthcare personnel wear facemasks instead.

 Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel can be viewed here.

 CDC also released a document with questions and answers to provide additional information intended to assist healthcare facilities in optimizing implementation of recommended respiratory protection practices in the context of shortages of respiratory protection equipment.

 Questions and Answers Regarding Respiratory Protection for Infection Control Measures for 2009 H1N1 Influenza among Healthcare Personnel are available here.

CDC Guidance on Prevention and Control

CDC has issued (or updated) guidance to help individuals, schools, businesses, and others take steps to avoid the flu and deal with its consequences.  All guidance can be accessed at http://www.cdc.gov/h1n1flu/guidance/. Below, we have provided direct links to key guidance that may be of interest.

Guidance for Schools

Guidance for Institutions of Higher Learning

Guidance for Childcare Facilities

Guidance for Business, Employers and Workplaces

Vaccination Guidance for State, Local, Tribal and Territorial Health Officials

Clinician Guidance Regarding Diagnostic Tests

Guidance for Individuals Handling 2009 H1N1 Clinical Specimens or Isolates

Guidance for Patients and Caretakers (and here)

Implementation Guidance for Managing Calls and Call Centers during a Large-Scale Influenza Outbreak

Guidance for Community Settings

Guidance for Travel and Travel Industry: Cruise Ships

Guidance for Travel and Travel Industry: Airlines

Guidance for the use of Antiviral Medications

Recommendations for Use of Antiviral Medications for the Management of Influenza in Children and Adolescent for the 2009-2010 Season -- Pediatric Supplement for Health Care Providers

Antiviral Safety Information

Interim Guidance for State and Local Health Departments for Reporting Influenza-Associated Hospitalizations and Deaths for the 2009-2010 Season

Guidance for Parents of Patients/Patients with Asthma  

Guidance for Clinicians Regarding Patients with Asthma

Communication Toolkit for the Federal Workforce

Guidance for Pregnant Women

Healthcare Providers and Facilities: Decision Tree for 2009 H1N1 Vaccination

Healthcare Providers and Facilities: Template Letter for Providers about the Vaccine Adverse Event Reporting System (VAERS)

Interim Guidance for Influenza Surveillance: Prioritizing RT-PCR Testing in Laboratories

2009 H1N1 Flu and Seasonal Flu Information for People with Inflammatory Arthritis or Rheumatic Disease

2009 H1N1 Flu and Seasonal Flu Information for Rheumatology Health Professionals

Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings, Including Protection of Healthcare Personnel

Questions and Answers Regarding Respiratory Protection for Infection Control Measures for 2009 H1N1 Influenza among Healthcare Personnel

Planning Guide for Vaccinating Pediatric Patients Against 2009 H1N1 Influenza in Primary Healthcare Settings

Updated Interim Recommendations—HIV-Infected Adults and Adolescents: Considerations for Clinicians Regarding 2009 H1N1 Influenza

2009-2010 Influenza Season Triage Algorithm for Children (≤18 years) With Influenza-Like Illness: For Use by Physicians

Communication Tools for Members and Constituents

CDC recognizes that H1N1 flu is of significant interest and concern to your constituents.  With this in mind, we offer cutting edge CDC communication tools you can use to effectively communicate information about 2009 H1N1 flu during the upcoming flu season:

  • Short (less than 140 characters) messages that you or your member can post to their Twitter account provide effective messages and shortened links to further information on H1N1
  • CDC and Flu.gov Twitter feeds (@CDCemergency, @CDCFlu, @CDC_ehealth, and @FluGov) that provide regularly updated information (and can be “re-tweeted” by members that use Twitter to disseminate information to constituents)
  • Buttons (in both English and Spanish), widgets, e-cards, and other tools that can be used on websites or in email newsletters
  • CDC’s image library, containing H1N1 flu-related images that can be used in your web materials and newsletters
  • CDC’s dedicated Youtube channel and other videos containing H1N1 and other health information
  • Podcasts of H1N1 and other health information, featuring CDC experts

All of these resources can be found at http://www.cdc.gov/SocialMedia/Campaigns/H1N1/. If you need technical assistance in using these tools, please contact Justin Cormier (jcormier@cdc.gov) or Andi Lipstein (alipstein@cdc.gov) in the CDC Washington Office.

We also have produced a variety of materials that can be printed at a local (or commercial) printer and distributed.  We do not stock these documents, but they can be useful handouts at district events. You can access these resources here.

New this week is a flyer urging first responders to get vaccinated, available here.

Foreign Language Resources

Some CDC information and resources are available in foreign languages. Such resources include:

Media Updates

CDC conducts regular media updates and briefings regarding 2009 H1N1 Influenza. Transcripts of these briefings, as well as audio recordings, are available here.

To the topTo The Top

 

  • Historical Document: October 23, 2009
  • Content source: CDC Washington
    Content Management: Office of Enterprise Communication
  • Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.